No Prescription |
 |
 | ||
|
Antinaus Stemitil |
|
| ||
No Prescription » Prescription Drugs 1 » Antinaus Stemitil This medication is used to treat severe nausea and vomiting from various causes (e.g. anti-cancer treatment migraine headaches after surgery).Prochlorperazine is a phenothiazine medication that works by affecting the balance of natural chemicals (neurotransmitters) in the brain to reduce nausea and the urge to vomit.This medication is not recommended for use in children under 2 years old or during surgery on children.How to use Prochlorperazine Maleate OralTake this medication by mouth with or without food as directed by your doctor.For the syrup use a medication measuring device to carefully measure the prescribed dose. Avoid getting the syrup on the skin since it may rarely cause skin reactions.The dosage is based on your age medical condition and response to therapy. Do not increase your dose or use this medication more often without your doctor's approval. Your condition will not improve any faster and the risk of serious side effects may be increased.If you are taking this medication on a prescribed schedule use it regularly in order to get the most benefit from it. To help you remember take it at the same time(s) each day.Inform your doctor if your condition persists or worsens. Buy Antinaus Stemitil and other Prescription Drugs 1 products online at Medstore. 335
About Antinaus Stemitil: Product Type: Prescription Drugs 1 Antinaus ( Stemitil Compazine Generic Prochlorperazine ) Antinaus (Stemitil Compazine Generic Prochlorperazine) Stemitil Compazine Generic Prochlorperazine 5mg tabs 500 Stemitil Compazine Generic Prochlorperazine Antinaus
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
